Fran Drescher has a reputation for passion and commitment. She received two Emmy and two Golden Globe nominations for her portrayal as the lovable "Miss Fine" on CBS’s hit series The Nanny, which she both created & executive produced. TV Land aired the ground-breaking sitcom Happily Divorced, which she also created, executive produced and starred in. The series was inspired by her own life; Fran played a woman sharing a loving friendship with her gay ex-husband.
An accomplished author, Fran received the prestigious NCCS writer’s award for Cancer Schmancer, which along with Enter Whining, were New York Times best sellers. Most recently she penned the celebrated children's book Being Wendy. Fran recently made her Broadway debut as “Madame” in Rodgers + Hammerstein’s Tony-award winning Cinderella. Her famous voice is currently featured in the top-grossing film Hotel Transylvania 2, in which she reprises her role as Eunice, the wife of Frank Stein.
A 17-year uterine cancer survivor, Fran turns lemons into lemonade and pain into purpose through her leadership as a cancer advocate. Her mission is to shift America’s focus toward proactive health care and healthy, toxin-free living. She believes that that the best cure for cancer is not getting it in the first place.
As Founder, President and Visionary of the non-profit Cancer Schmancer Movement, she focuses on three prongs to fight the disease: Early Detection, Prevention, and Advocacy.
On Oct. 24, 2017, Fran Drescher presented Cancer Schmancer's third annual Health Summit at the Dorothy Chandler Pavilion in Los Angeles. Her mission is to transform passive patients into active medical consumers.
Some of the health organization’s accomplishments include early detection Fran Vans provide free mammograms to women without access to health care. Its Detox Your Home prevention campaign educates people of all ages to reduce risk through healthy living, and Fran uses her unique voice on Capitol Hill to advocate for a range of health issues.
Fran was instrumental in passing the bi-partisan ”Gynecologic Cancer Education and Awareness Act” by unanimous consent, earning her two commendations in the Congressional Record. She is a U.S. State Department Public Diplomacy Envoy for Women’s Health, traveling globally to meet with heads of state, cancer patients, local NGOs, as well as military bases and hospitals. The Washingtonian named her one of the most effective celebrity lobbyists in D.C.
Fran has won countless awards for her leadership in the health space, including the John Wayne Institute Woman of Achievement Award, the Gilda Award, City of Hope Woman of the Year Award, The
Albert Einstein Medical School Lifetime Achievement Award, Queens College Lifetime Achievement Award (2017), and the 2014 Citizen Artist Award. The Knesset in Israel honored Fran as the first Jewish actress who played an openly Jewish character embraced by not only Israel, but by many Arab nations.
Fran was also honored with the Human Rights Campaign’s Ally for Equality Award for her efforts to defend civil liberties and, most recently, the Stonewall and Liberty Bell Awards for her advocacy of Gay Civil Liberties
Fran's other passions are protecting the environment, arts in education, and organic food.
Analytical Science Keynote
Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI).
Previously, from 2015-2017, he was Medical Director of PHYTECS, a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system (ECS). From 2003-2014, he served as Senior Medical Advisor, medical monitor and study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex® for intractable epilepsy.
He graduated from the University of Pennsylvania (Psychology), and the University of Massachusetts Medical School, before residencies in Pediatrics in Phoenix, Arizona and in Child and Adult Neurology at the University of Washington in Seattle. He was a clinical neurologist in Missoula, Montana for 20 years.
He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, in Medicine at the University of Washington, and as visiting professor, Harvard University, Johns Hopkins University, and the Chinese Academy of Sciences.
He is a former president of the International Cannabinoid Research Society and former Chairman of the International Association for Cannabinoid Medicines. He serves on the Scientific Advisory Board for the American Botanical Council. He is author/editor of seven books on cannabis and medicinal herbs, and has also published numerous book chapters, and over fifty articles in neurology, pain management, cannabis, and ethnobotany. He has consulted or lectured on these topics in 38 states and Canadian provinces and 34 countries.
Analytical Science Keynote
David Meiri, PhD, is Associate Professor at the Faculty of Biology at the Technion and a member of the Technion Integrated Cancer Center (TICC). Dr. Meiri holds a M.Sc. in Biochemistry and a Ph.D. in plant biotechnology from Tel Aviv University. He conducted his post-doctoral fellowship at the Ontario Cancer Institute where he focused on tumor invasion and metastasis. During his post-doctoral studies, he expanded his knowledge in human biology and cancer pathogenesis and gained worldwide recognition as an expert in the fields of G-protein coupled receptors (GPCRs), small GTPases and cytoskeleton. Upon completion of his post-doctoral fellowship, Dr Meiri took a position at the Technion Israel Institute of Technology, where he heads the "Laboratory of Cancer Biology and Cannabinoid Research". Presently, his lab investigates the therapeutic potential of phytocannabinoids, with focus on the antitumor effects of cannabinoids. In addition to the laboratory cannabis research performed on-site, Dr. Meiri collaborates with cannabis growers, clinicians, major manufacturers and distributors of medical cannabis for the purpose of revolutionizing cannabis treatment. He is operating the "Cannabis Database Project" and his lab is currently involved in eight clinical trials covering diverse aspects of cannabis treatment such as colon disease, pain prevention, cancer treatment and epilepsy.
Medical Cannabis Keynote
Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness and Education, a California-based medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions. After years of working in the specialty of Pediatric Emergency medicine, she developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend. Since then she has evaluated thousands of patients for use of medical cannabis. She has a special interest in treating children with intractable epilepsy, autism, and advanced cancers, as well as adults with chronic pain, autoimmune illnesses and other endocannabinoid deficiency disorders. Dr. Goldstein recently authored the book “Cannabis Revealed: How the world’s most misunderstood plant is treating everything from chronic pain to epilepsy.” She is also the medical advisor to Weedmaps.com.
A frequent speaker both nationally and internationally, Dr. Goldstein has presented her clinical results at the CannMed Conference, Patients Out of Time Conference, Medical Cannabis Symposium in Sydney, Australia, and most recently at Balkannabis 2018 in Athens, Greece. She has appeared numerous times on the TV show The Doctors and is featured in the soon-to-be released documentary “Weed the People”.
Medical Cannabis Keynote
Tracy Ryan is the CEO for CannaKids, a California-based company with a focus on supplying medical cannabis oil to adults and children looking for holistic relief for serious health conditions. She is also the CEO of CK Sciences whose focus has been to plan and execute pre-clinical and clinical pediatric trials using cannabis medicine in the US and around the world.
In addition, Tracy founded the 501c3 non-profit, Saving Sophie Inc (SavingSophie.org). Their mission is to provide educational resources and financial support to families whose loved one have been diagnosed with a serious illness or disease.
Since her infant daughter’s brain tumor diagnosis in June of 2013, Tracy has dedicated her life to educating herself on the medicinal powers of medical cannabis in treating her own daughter’s disease, as well as all other pediatric and adult cancers, autism, epilepsy and beyond. Tracy has worked on a global scale with families who are seeking education and treatment options for their loved ones, and has guided many patients to unheard of success.
Tracy has partnered with, and is on the Advisory Board of, CURE Pharmaceutical, (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, and the Technion Institute in Israel who is leading the way in cannabis research for cancer. Furthermore, CK Sciences & CURE are funding the next four years of this research where both pediatric and adult cancers will be studied for cannabinoid sensitivity. .
Additionally, Tracy has successfully procured Sophie’s brain tumor tissue after a recent brain surgery, and those cells are now being rigoursly studied under the leadership of renowned cancer researcher Dr. Anadis Jewett at UCLA. Sophie has her own IRB which means she has a pre-clinical trial all her own. Dr. Jewett has additionaly implanted Sophie’s tissue into mice, one of which pumps human blood. These are the only mice of their kind in the world using Dr. Jewett’s patented procedure. Their main goal is to find a cure for Sophie. In return, this could help many other children like her.
Tracy and CannaKids have been the recipient of several industry awards, furthering her strength in the cannabis community as a key player. She was also chosen to be one of only 9 people to be on the University of California at Irvine's Task Force that will work to design the first ever cannabis multidisciplinary college.
Tracy and her family have been featured in many national and international news pieces including an appearance on The Doctors, National Geographic, Vice News, CNN, Entertainment Tonight, The Huffington Post, Telemundo, and many more. They are also the key focus of the Ricki Lake and Abby Epstein documentary, “Weed The People”.
Cultivation Science Keynote
Autumn Karcey is the CEO and founder of Cultivo, Inc., a design and engineering firm located in Southern California specializing in industry specific solutions for the cannabis industry. Cultivo, Inc. designs greenhouses as well as closed loop indoor cultivation and research facilities worldwide.
Over the past fourteen years, Ms. Karcey has honed her skills in many aspects of the cannabis industry including permit acquisition, cultivation, facility design, and environmental optimization. As one of Los Angeles’s leading medicinal cannabis cultivators for over a decade Ms. Karcey was in charge of vertically integrating medical cannabis to over twenty Pre-ICO dispensaries in and around Los Angeles, CA. This model created a zero tolerance for crop failure and made it imperative for Ms. Karcey to create optimal indoor environments in which cannabis can be grown in a healthy, stable manner free of pests and pathogens without the use of harmful pesticides and chemicals.
Ms. Karcey takes a logical, consistent, and scientific approach when she designs cultivation sites. She combines the use of modern clean room technology, industrial agricultural equipment, custom fabricated equipment, high-end security systems, and sensor systems in order to create world-class facilities of enduring value. To date, Ms. Karcey has built, designed, and consulted on facilities in over ten US states and thee countries totaling over two-million square feet of canopy area. Ms. Karcey’s current designs include a 30,000 square foot facility on the Big Island of Hawaii and over 200,000 square feet currently under development in California. Together, Ms. Karcey and her team of industry specific professionals -- comprised of architects, engineers, cultivators, and scientists -- work together to provide aid and understanding of indoor, greenhouse cultivation environments for optimum plant health.
Overall, Ms. Karcey’s goal is to help educate lawmakers, patients, and scientists in order to implement standards and protocol for future facilities by maintaining the highest standards of quality assurance in order to deliver safe effective medical grade cannabis to the scientific community for research and development, as well as medical patients in all legal markets.
Cultivation Science Keynote
Dr. Jacklyn R. Green is a project manager and systems engineer focused on commercial businesses in the cannabis industry. With her PhD from The University of Texas at Austin, she leads, manages, and delivers compliant, compelling, and selectable applications for city- and state-legal commercial cannabis businesses. She spent 27 years at NASA’s Jet Propulsion Laboratory as a scientist and project manager, leading advanced technology development projects and proposal development in the complex government-regulated environment. Now, as the Chief Executive Officer of Agate Biosciences, a consulting firm for Project Management, Systems Engineering, and Science for Controlled Environment Agriculture, she brings the best practices of management and systems engineering to cannabis businesses allowing them to be successful in the complex, government-regulated environment.
Cultivation Science Keynote
Dr. Roger Kern is a scientist and technologist who cares deeply about the cultivation and health of plants in the cannabis industry. With his PhD in microbiology from the University of California Davis, Plant Growth Laboratory, he solves the most challenging problems in hydroponics, from studying the root microbiome to developing nutrients and lighting systems to ensure plant health and a disease-free lifecycle. He spent 22 years at NASA’s Jet Propulsion Laboratory as a scientist, technologist, and research leader before becoming the President of Agate Biosciences, a consulting firm for Project Management, Systems Engineering, and Science in CEA for the past eight years. He leads developments to optimize sustainability, consistency, quality, and yield, without compromising plant health.
Analytical Cannabis Speakers
Medical Cannabis Speakers